THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s Holding History (CIK: 0001705339)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 38,170 Value ($000) $714 Avg Close $16.59 Range $13.50 - $20.33

Q3 2025

Shares 37,611 Value ($000) $549 Avg Close $12.64 Range $10.82 - $14.87

Q2 2025

Shares 39,046 Value ($000) $431 Avg Close $9.72 Range $7.90 - $11.82

Q1 2025

Shares 40,343 Value ($000) $360 Avg Close $9.31 Range $8.35 - $10.90

Q4 2024

Shares 39,803 Value ($000) $375 Avg Close $9.10 Range $7.88 - $10.26

Q3 2024

Shares 39,211 Value ($000) $316 Avg Close $8.66 Range $7.44 - $10.42

Q2 2024

Shares 43,266 Value ($000) $367 Avg Close $9.03 Range $8.13 - $10.44

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	38,170	$714	$16.59	$13.50 - $20.33
Q3 2025	37,611	$549	$12.64	$10.82 - $14.87
Q2 2025	39,046	$431	$9.72	$7.90 - $11.82
Q1 2025	40,343	$360	$9.31	$8.35 - $10.90
Q4 2024	39,803	$375	$9.10	$7.88 - $10.26
Q3 2024	39,211	$316	$8.66	$7.44 - $10.42
Q2 2024	43,266	$367	$9.03	$8.13 - $10.44